logo
Login

AUROBINDO PHARMA LTD (AUROPHARMA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)

AUROPHARMAUpdated 6 Sept 2026, 23:21

Aurobindo Pharma Ltd

Market Cap

₹95,116Cr.

Current Price

₹1,653

High / Low

₹1,717/1,035

Stock P/E

36.5

ROE11.2%
ROCE13.0%
Book Value₹391
Face Value₹1.00
Dividend Yield0.24%

About

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days168175143159156158137128197129140138
Inventory Days207207191273235242244210335148154161
Days Payable11110996130109107104104179112116125
Cash Conversion Cycle264273239301282293277234353166177174
Working Capital Days1088492106107132118181126653227
ROCE %27%24%20%19%15%16%23%9%8%12%11%13%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 6 September 2026 at 23:21

Designed & Shipped by Harshit Bansal